Elimination Disorders: Clinical Trials

5 trials for Elimination Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 22Completed 2

Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence
Infusion of mesenchymal stem cells from adipose tissue, Infusion of placebo - Faecal Incontinence
Phase 1 / Phase 2CompletedAndalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud162013-10-012018-04-17
Autologous Cell Therapy for Treatment of Fecal Incontinence
Iltamiocel - Fecal Incontinence
Phase 1 / Phase 2CompletedCook MyoSite532013-03-282024-02-16
A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg
DWETR10, DWETR25 - Depression, Depressive State
Phase 1CompletedDong Wha Pharmaceutical Co. Ltd.122011-07-012014-08-22
Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
NRL001 cream 0.5%w/w, NRL001 cream 0.75%w/w, NRL001 cream 1.0%w/w - Faecal Incontinence
Phase 1CompletedNorgine722007-08-012024-09-19
The Safety and Dose Response to Single Anal Doses of NRL001
Perianal NRL001 Gel 3 strengths, Intraanal NRL001 Gel 2 strengths, Intrarectal NRL001 Gel - Faecal Incontinence
Phase 1CompletedNorgine442002-12-012024-09-19

Narrower conditions

Encopresis (4)  ·  Depression (1)  ·  Enuresis (1)  ·  Fecal Incontinence (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Rectal Diseases (1)  ·  Urinary Incontinence (1)

Broader conditions

Behavior (5)  ·  Behavioral Symptoms (5)  ·  Mental Disorders (5)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Digestive (4)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Digestive System Diseases (1)  ·  Lower Urinary Tract Symptoms (1)

Interventions

Suppositories (1)

Sponsors

Norgine (2)  ·  Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1)  ·  Cook MyoSite (1)  ·  Dong Wha Pharmaceutical Co. Ltd. (1)

Countries

United Kingdom (2)  ·  Canada (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Fernando de la Portilla, Dr. (1)  ·  John H Scholefield, MD (1)  ·  Manoj J Raval, MD (1)  ·  Min-Gul Kim, MD, PhD (1)  ·  Santiago Mera, Dr. (1)

Results publications

PMID 25308868, PMID 37144409